Search Results - "Drakou, Athina"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Creatinine index as a predictive marker of sarcopenia in patients under hemodialysis by Plytzanopoulou, Petrini, Politis, Panagiotis, Papachrysanthou, Theodora, Andriopoulos, Christos, Drakou, Athina, Papachristou, Evangelos, Papastamatiou, Miltiadis, Papasotiriou, Marios

    Published in International urology and nephrology (01-07-2022)
    “…Purpose Sarcopenia is a clinical condition that comprises declined skeletal muscle (SM) mass and SM strength, and is a risk factor for physical disability,…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Assessment of Serum Bioactive Hepcidin-25, Soluble Transferrin Receptor and Their Ratio in Predialysis Patients: Correlation with the Response to Intravenous Ferric Carboxymaltose Administration by Drakou, Athina, Poziopoulos, Christos, Margeli, Alexandra, Papassotiriou, Ioannis, Vlahakos, Demetrios

    Published in Blood (03-12-2015)
    “…Background: No reliable biomarker exists to predict responsiveness to intravenous (IV) iron (Fe) in iron deficient patients with chronic kidney disease (CKD)…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Spironolactone improves endothelial and cardiac autonomic function in non heart failure hemodialysis patients by Flevari, Panayota, Kalogeropoulou, Sofia, Drakou, Athina, Leftheriotis, Dionyssios, Panou, Fotis, Lekakis, John, Kremastinos, Demetrios, Vlahakos, Demetrios V

    Published in Journal of hypertension (01-06-2013)
    “…OBJECTIVES:Hemodialysis patients have a cardiovascular mortality rate of 20–40 times that of the general population. Aldosterone inhibition by spironolactone…”
    Get full text
    Journal Article
  8. 8